カテゴリー： QYResearch, 世界, 部品/材料

世界のチカグレロルAPI市場インサイト及び予測（純度≥99%、純度≥99.5%以上）

◆英語タイトル：Global Ticagrelor API Market Insights, Forecast to 2028
	◆商品コード：QY22JLX02710 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：105 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥725,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,087,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,450,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、チカグレロルAPIのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にチカグレロルAPIの世界市場のxxx％を占める「純度≥99%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
チカグレロルAPIの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのチカグレロルAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

チカグレロルAPIのグローバル主要企業には、SUANFARMA、Metrochem API Pvt Ltd、Divi's Laboratories、CTX、Shanghai Haoyuan Chemexpress、CR Double Crane、Tianyu Pharm、Chem-Stone、Hunan Warrant、Jiangxi Synergy Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

チカグレロルAPI市場は、種類と用途によって区分されます。世界のチカグレロルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99%、純度≥99.5%以上

【用途別セグメント】
錠剤、カプセル、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- チカグレロルAPI製品概要
- 種類別市場（純度≥99%、純度≥99.5%以上）
- 用途別市場（錠剤、カプセル、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のチカグレロルAPI販売量予測2017-2028
- 世界のチカグレロルAPI売上予測2017-2028
- チカグレロルAPIの地域別販売量
- チカグレロルAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別チカグレロルAPI販売量
- 主要メーカー別チカグレロルAPI売上
- 主要メーカー別チカグレロルAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99%、純度≥99.5%以上）
- チカグレロルAPIの種類別販売量
- チカグレロルAPIの種類別売上
- チカグレロルAPIの種類別価格
・用途別市場規模（錠剤、カプセル、その他）
- チカグレロルAPIの用途別販売量
- チカグレロルAPIの用途別売上
- チカグレロルAPIの用途別価格
・北米市場
- 北米のチカグレロルAPI市場規模（種類別、用途別）
- 主要国別のチカグレロルAPI市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのチカグレロルAPI市場規模（種類別、用途別）
- 主要国別のチカグレロルAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のチカグレロルAPI市場規模（種類別、用途別）
- 主要国別のチカグレロルAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のチカグレロルAPI市場規模（種類別、用途別）
- 主要国別のチカグレロルAPI市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのチカグレロルAPI市場規模（種類別、用途別）
- 主要国別のチカグレロルAPI市場規模（トルコ、サウジアラビア）
・企業情報
SUANFARMA、Metrochem API Pvt Ltd、Divi's Laboratories、CTX、Shanghai Haoyuan Chemexpress、CR Double Crane、Tianyu Pharm、Chem-Stone、Hunan Warrant、Jiangxi Synergy Pharmaceutical
・産業チェーン及び販売チャネル分析
- チカグレロルAPIの産業チェーン分析
- チカグレロルAPIの原材料
- チカグレロルAPIの生産プロセス
- チカグレロルAPIの販売及びマーケティング
- チカグレロルAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- チカグレロルAPIの産業動向
- チカグレロルAPIのマーケットドライバー
- チカグレロルAPIの課題
- チカグレロルAPIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Ticagrelor API Market
Due to the COVID-19 pandemic, the global Ticagrelor API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Ticagrelor API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
China Ticagrelor API market size is valued at US$ million in 2021, while the US and Europe Ticagrelor API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ticagrelor API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ticagrelor API include SUANFARMA, Metrochem API Pvt Ltd, Divi’s Laboratories, CTX, Shanghai Haoyuan Chemexpress, CR Double Crane, Tianyu Pharm, Chem-Stone and Hunan Warrant and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Ticagrelor API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Ticagrelor API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Ticagrelor API Scope and Segment
Ticagrelor API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ticagrelor API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Tablet
Capsule
Other
By Company
SUANFARMA
Metrochem API Pvt Ltd
Divi’s Laboratories
CTX
Shanghai Haoyuan Chemexpress
CR Double Crane
Tianyu Pharm
Chem-Stone
Hunan Warrant
Jiangxi Synergy Pharmaceutical
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Ticagrelor API Product Introduction
1.2 Market by Type
1.2.1 Global Ticagrelor API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Ticagrelor API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Ticagrelor API Production
2.1 Global Ticagrelor API Production Capacity (2017-2028)
2.2 Global Ticagrelor API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Ticagrelor API Production by Region
2.3.1 Global Ticagrelor API Historic Production by Region (2017-2022)
2.3.2 Global Ticagrelor API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Ticagrelor API Sales in Volume & Value Estimates and Forecasts
3.1 Global Ticagrelor API Sales Estimates and Forecasts 2017-2028
3.2 Global Ticagrelor API Revenue Estimates and Forecasts 2017-2028
3.3 Global Ticagrelor API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Ticagrelor API Sales by Region
3.4.1 Global Ticagrelor API Sales by Region (2017-2022)
3.4.2 Global Sales Ticagrelor API by Region (2023-2028)
3.5 Global Ticagrelor API Revenue by Region
3.5.1 Global Ticagrelor API Revenue by Region (2017-2022)
3.5.2 Global Ticagrelor API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Ticagrelor API Production Capacity by Manufacturers
4.2 Global Ticagrelor API Sales by Manufacturers
4.2.1 Global Ticagrelor API Sales by Manufacturers (2017-2022)
4.2.2 Global Ticagrelor API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Ticagrelor API in 2021
4.3 Global Ticagrelor API Revenue by Manufacturers
4.3.1 Global Ticagrelor API Revenue by Manufacturers (2017-2022)
4.3.2 Global Ticagrelor API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Ticagrelor API Revenue in 2021
4.4 Global Ticagrelor API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Ticagrelor API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Ticagrelor API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Ticagrelor API Sales by Type
5.1.1 Global Ticagrelor API Historical Sales by Type (2017-2022)
5.1.2 Global Ticagrelor API Forecasted Sales by Type (2023-2028)
5.1.3 Global Ticagrelor API Sales Market Share by Type (2017-2028)
5.2 Global Ticagrelor API Revenue by Type
5.2.1 Global Ticagrelor API Historical Revenue by Type (2017-2022)
5.2.2 Global Ticagrelor API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Ticagrelor API Revenue Market Share by Type (2017-2028)
5.3 Global Ticagrelor API Price by Type
5.3.1 Global Ticagrelor API Price by Type (2017-2022)
5.3.2 Global Ticagrelor API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Ticagrelor API Sales by Application
6.1.1 Global Ticagrelor API Historical Sales by Application (2017-2022)
6.1.2 Global Ticagrelor API Forecasted Sales by Application (2023-2028)
6.1.3 Global Ticagrelor API Sales Market Share by Application (2017-2028)
6.2 Global Ticagrelor API Revenue by Application
6.2.1 Global Ticagrelor API Historical Revenue by Application (2017-2022)
6.2.2 Global Ticagrelor API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Ticagrelor API Revenue Market Share by Application (2017-2028)
6.3 Global Ticagrelor API Price by Application
6.3.1 Global Ticagrelor API Price by Application (2017-2022)
6.3.2 Global Ticagrelor API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Ticagrelor API Market Size by Type
7.1.1 North America Ticagrelor API Sales by Type (2017-2028)
7.1.2 North America Ticagrelor API Revenue by Type (2017-2028)
7.2 North America Ticagrelor API Market Size by Application
7.2.1 North America Ticagrelor API Sales by Application (2017-2028)
7.2.2 North America Ticagrelor API Revenue by Application (2017-2028)
7.3 North America Ticagrelor API Sales by Country
7.3.1 North America Ticagrelor API Sales by Country (2017-2028)
7.3.2 North America Ticagrelor API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Ticagrelor API Market Size by Type
8.1.1 Europe Ticagrelor API Sales by Type (2017-2028)
8.1.2 Europe Ticagrelor API Revenue by Type (2017-2028)
8.2 Europe Ticagrelor API Market Size by Application
8.2.1 Europe Ticagrelor API Sales by Application (2017-2028)
8.2.2 Europe Ticagrelor API Revenue by Application (2017-2028)
8.3 Europe Ticagrelor API Sales by Country
8.3.1 Europe Ticagrelor API Sales by Country (2017-2028)
8.3.2 Europe Ticagrelor API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Ticagrelor API Market Size by Type
9.1.1 Asia Pacific Ticagrelor API Sales by Type (2017-2028)
9.1.2 Asia Pacific Ticagrelor API Revenue by Type (2017-2028)
9.2 Asia Pacific Ticagrelor API Market Size by Application
9.2.1 Asia Pacific Ticagrelor API Sales by Application (2017-2028)
9.2.2 Asia Pacific Ticagrelor API Revenue by Application (2017-2028)
9.3 Asia Pacific Ticagrelor API Sales by Region
9.3.1 Asia Pacific Ticagrelor API Sales by Region (2017-2028)
9.3.2 Asia Pacific Ticagrelor API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Ticagrelor API Market Size by Type
10.1.1 Latin America Ticagrelor API Sales by Type (2017-2028)
10.1.2 Latin America Ticagrelor API Revenue by Type (2017-2028)
10.2 Latin America Ticagrelor API Market Size by Application
10.2.1 Latin America Ticagrelor API Sales by Application (2017-2028)
10.2.2 Latin America Ticagrelor API Revenue by Application (2017-2028)
10.3 Latin America Ticagrelor API Sales by Country
10.3.1 Latin America Ticagrelor API Sales by Country (2017-2028)
10.3.2 Latin America Ticagrelor API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Ticagrelor API Market Size by Type
11.1.1 Middle East and Africa Ticagrelor API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Ticagrelor API Revenue by Type (2017-2028)
11.2 Middle East and Africa Ticagrelor API Market Size by Application
11.2.1 Middle East and Africa Ticagrelor API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Ticagrelor API Revenue by Application (2017-2028)
11.3 Middle East and Africa Ticagrelor API Sales by Country
11.3.1 Middle East and Africa Ticagrelor API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Ticagrelor API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 SUANFARMA
12.1.1 SUANFARMA Corporation Information
12.1.2 SUANFARMA Overview
12.1.3 SUANFARMA Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 SUANFARMA Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 SUANFARMA Recent Developments
12.2 Metrochem API Pvt Ltd
12.2.1 Metrochem API Pvt Ltd Corporation Information
12.2.2 Metrochem API Pvt Ltd Overview
12.2.3 Metrochem API Pvt Ltd Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Metrochem API Pvt Ltd Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Metrochem API Pvt Ltd Recent Developments
12.3 Divi’s Laboratories
12.3.1 Divi’s Laboratories Corporation Information
12.3.2 Divi’s Laboratories Overview
12.3.3 Divi’s Laboratories Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Divi’s Laboratories Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Divi’s Laboratories Recent Developments
12.4 CTX
12.4.1 CTX Corporation Information
12.4.2 CTX Overview
12.4.3 CTX Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 CTX Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 CTX Recent Developments
12.5 Shanghai Haoyuan Chemexpress
12.5.1 Shanghai Haoyuan Chemexpress Corporation Information
12.5.2 Shanghai Haoyuan Chemexpress Overview
12.5.3 Shanghai Haoyuan Chemexpress Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Shanghai Haoyuan Chemexpress Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Shanghai Haoyuan Chemexpress Recent Developments
12.6 CR Double Crane
12.6.1 CR Double Crane Corporation Information
12.6.2 CR Double Crane Overview
12.6.3 CR Double Crane Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 CR Double Crane Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 CR Double Crane Recent Developments
12.7 Tianyu Pharm
12.7.1 Tianyu Pharm Corporation Information
12.7.2 Tianyu Pharm Overview
12.7.3 Tianyu Pharm Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Tianyu Pharm Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Tianyu Pharm Recent Developments
12.8 Chem-Stone
12.8.1 Chem-Stone Corporation Information
12.8.2 Chem-Stone Overview
12.8.3 Chem-Stone Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Chem-Stone Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Chem-Stone Recent Developments
12.9 Hunan Warrant
12.9.1 Hunan Warrant Corporation Information
12.9.2 Hunan Warrant Overview
12.9.3 Hunan Warrant Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Hunan Warrant Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Hunan Warrant Recent Developments
12.10 Jiangxi Synergy Pharmaceutical
12.10.1 Jiangxi Synergy Pharmaceutical Corporation Information
12.10.2 Jiangxi Synergy Pharmaceutical Overview
12.10.3 Jiangxi Synergy Pharmaceutical Ticagrelor API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Jiangxi Synergy Pharmaceutical Ticagrelor API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Jiangxi Synergy Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Ticagrelor API Industry Chain Analysis
13.2 Ticagrelor API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Ticagrelor API Production Mode & Process
13.4 Ticagrelor API Sales and Marketing
13.4.1 Ticagrelor API Sales Channels
13.4.2 Ticagrelor API Distributors
13.5 Ticagrelor API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Ticagrelor API Industry Trends
14.2 Ticagrelor API Market Drivers
14.3 Ticagrelor API Market Challenges
14.4 Ticagrelor API Market Restraints
15 Key Finding in The Global Ticagrelor API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のチカグレロルAPI市場インサイト及び予測（純度≥99%、純度≥99.5%以上）(Global Ticagrelor API Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のチカグレロルAPI市場インサイト及び予測（純度≥99%、純度≥99.5%以上）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp